Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help

Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Multiple Myeloma Clinical Trials

Protocol Number Title
1999LS060
MT1999-14 Unrelated or partially matched allogeneic donor stem cells for lymphoma, myeloma, and chronic lymphocytic leukemia
2001LS058
MT2001-10 Allogeneic Bone Marrow Transplant Using Less Intensive Therapy
2004LS001
MT2003-13 Autologous Transplantation for Multiple Myeloma
2005LS036
MT2005-02 Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Hematological Malignancies Using a Non-Myeloablative Preparative Regimen
2005LS043
MT2005-10 Transplantation of Unrelated Umbilical Cord Blood for Patients with Hematological Diseases with Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloblative Preparative Regimen
2012LS023
HM2013-12: IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic Stem Cell Transplantation
2012LS089
MT2012-17R:Safety of Nplate? in Patients Who Have Failed to Achieve Platelet Engraftment Following Umbilical Cord Blood Transplant
2012NTLS024
MT2012-24R Preparative Regimen Exposure-Response Relationships in Nonmyeloablative Stem Cell Transplants: Correlative Pharmacokinetics.
2012OC065
MT2012-11C: Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
2013OC003
MT2013-06C : Treatment of graft Failure after HSCT
2013OC116
MT2013-33C:REDUCED INTENSITY (RIC) CONDITIONING AND TRANSPLANTATION OF HLA-HAPLOIDENTICAL RELATED BONE MARROW (HAPLO-BM) FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2014CG126
MT2014-33R: Continued Long-Term Follow-up and Lenalidomide Maintenance Therapy for Patients Who have Enrolled on CTN 0702 (CTN 07LT)
2014LS020
MT2014-12:Phase I/II Study of Human Chorionic Gonadotropin and Epidermal Growth Factor Supplementation (Pregnyl?) to Support Tolerance and Repair As Adjunct Therapy in High-Risk or Refractory Acute Graft-Versus-Host Disease
2014NTLS071
Family-based studies of susceptibility to early onset disease
2015EX065
Expanded Access, Single Patient Use of Elotuzumab in Combination with Lenlidomide plus Dexamethasone for Multiple Myeloma
2015NTIS093
MT2015-21R: A follow-up study that evaluates the safety and clinical outcomes of subjects who have undergone hematopoietic stem cell transplantation with HSC835 (expanded umbilical cord blood hematopoietic stem cells)
2015NTLS018
MT2015-08R: Microbial, Graft and Host Interactions in Hematopoietic Cell Transplantation Reducing sepsis-related mortality in cancer patients through microbiome therapy
2016CG095
MT2016-13 :A Randomized, Phase II, Multicenter, Open Label, Study Evaluating Sirolimus and Prednisone in Patients with Refined Minnesota Standard Risk, Ann Arbor 1/2 Confirmed Acute Graft-Versus-Host Disease (CTN 1501)
2016IS064
MT2016-10: A Phase 2a, Dose-Escalation, Open-Label Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects with Chronic Graft Versus Host Disease

19 trials displayed